46014-0296 Talzenna - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

46014-0296

Brand Name:

Talzenna

Generic Name:

talazoparib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: TALAZOPARIB TOSYLATE

Strength: 0.25

Unit: mg/1

Packages:

Code: 46014-0296-01

Description: 30 CAPSULE in 1 BOTTLE (46014-0296-1)

Effective Date: Oct. 26, 2018

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

PARP

Orphan Drug Designation:

Status:

In Use